Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia

Free Radical Research

Volumn 45, Issue 9, 2011, Pages 1024-1032

  Joung, Kyoung Eun ^a,c   Kim, Han Suk ^a   Lee, Juyoung ^a   Shim, Gyu Hong ^a,b   Choi, Chang Won ^a   Kim, Ee Kyung ^a   Kim, Beyong Il ^a   Choi, Jung Hwan ^a  

^a Seoul National University Children's Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

8 hydroxydeoxyguanosine; Chronic lung disease; Leukotrienes; Pre term infants; Systematic inflammatory response

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; LEUKOTRIENE E4;

ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; INFANT; LUNG DISEASE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; URINALYSIS; VERY LOW BIRTH WEIGHT;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; DEOXYGUANOSINE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INFLAMMATION; LEUKOTRIENE E4; MALE; OXIDATIVE STRESS; STATISTICS AS TOPIC;

EID: 79961163119     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.588229     Document Type: Article

References (34)

1. Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
2. Jobe A. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-643.
3. Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 1999;103: 759-765. (Pubitemid 29274468)
4. Panickar J, Scholefield H, Kumar Y, Pilling DW, Subhedar NV. Atypical chronic lung disease in preterm infants. J Perinat Med 2004;32:162-167. (Pubitemid 39220538)
5. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610.
6. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fl uid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-830. (Pubitemid 27516049)
7. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal infl ammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-779. (Pubitemid 29503589)
8. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002;140:171-176. (Pubitemid 34183655)
9. Choi CW, Kim BI, Kim HS, Park JD, Choi JH, Son DW. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Paediatr 2006;95:38-43. (Pubitemid 43041726)
10. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung infl ammation in preterm newborns. Pediatr Res 1996;39: 966-975.
11. Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW, et al. Infl ammatory markers in intrauterine and fetal blood and cerebrospinal fl uid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004;55:1009-1017. (Pubitemid 38661794)
12. Speer CP. Infl ammation and bronchopulmonary dysplasia. Semin Neonatol 2003;8:29-38.
13. Kim DH, Kim HS, Shim SY, Lee JA, Choi CW, Kim EK, et al. Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia. Neonatology 2008;93:223-229. (Pubitemid 351799099)
14. Saugstad OD. Chronic lung disease: the role of oxidative stress. Biol Neonate 1998;74(Suppl 1):21-28. (Pubitemid 28425288)
15. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-49.
16. Choi CW, Kim BI, Hong JS, Kim EK, Kim HS, Choi JH. Bronchopulmonary dysplasia in a rat model induced by intraamniotic infl ammation and postnatal hyperoxia: morphometric aspects. Pediatr Res 2009;65:323-327.
17. Evans M, Palta M, Sadek M, Weinstein MR, Peters ME. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. Am J Epidemiol 1998;148:460-466. (Pubitemid 28411103)
18. Westcott JY, Smith HR, Wenzel SE, Larsen GL, Thomas RB, Felsien D, Voelkel NF. Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Am Rev Respir Dis 1991;143:1322-1328.
19. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339: 1-9. (Pubitemid 37542453)
20. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729. (Pubitemid 32578778)
21. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fl uid from women with clinical intraamniotic infection at term. J Infect Dis 1982;145:1-8 (Pubitemid 12212411)
22. Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: a practitioner's perspective. Pediatr Rev 1988;9: 219-226.
23. Volpe JJ. Intracranial hemorrhage: germinal matrix-intraventicular hemorrhage of the premature infant. In: Neurology of the Newborn. 5 th ed. Philadelphia, PA: Saunders; 2008. p 517-588.
24. Ogihara T, Kim H-S, Hirano K, Imanishi M, Ogihara H, Tamai H, et al. Oxydation products of uric acid and ascorbic acid in preterm infants with chronic lung disease. Biol Neonate 1998;73:24-33. (Pubitemid 28014519)
25. Subramaniam M, Bausch C, Twomey A, Andreeva S, Yoder BA, Chang L, et al. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2007;176:902-912. (Pubitemid 350097080)
26. Reuter SD, O'Donovan DJ, Hegemier SE, Smith EO, Heird WC, Fernandes CJ. Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia. J Perinatol 2007;27:303-306. (Pubitemid 46647908)
27. Chessex P, Watson C, Kaczala GW, Rouleau T, Lavoie ME, Friel J, Lavoie JC. Determinants of oxidant stress in extremely low birth weight premature infants. Free Radic Biol Med 2010;49:1380-1386.
28. Ogihara T, Hirano K, Morinobu T, Kim HS, Ogawa S, Hiroi M, et al. Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia. Pediatr Res 2006;60:613-618. (Pubitemid 44627412)
29. Matsubasa T, Uchino T, Karashima S, Kondo Y, Maruyama K, Tanimura M, Endo F. Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radic Res 2002;36:189-193.
30. Ates O, Alp HH, Caner I, Yildirim A, Tastekin A, Kocer I, Baykal O. Oxidative DNA damage in retinopathy of prematurity. Eur J Ophthalmol 2009;19:80-85.
31. Walsh SW. Evidence for 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene C4(LTC4) in the onset of labor. Ann N Y Acad Sci 1991;622:341-354.
32. Halvorsen T, Skadberg BT, Eide GE, Roksund O, Aksnes L, Oymar K. Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy Immunol 2005;16:487-494. (Pubitemid 41414990)
33. Davidson D, Drafta D, Wilkens BA. Elevated urinary leukotriene E4 in chronic lung disease of extreme prematurity. Am J Respir Crit Care Med 1995;151:841-845.
34. Sheikh S, Null D, Gentile D, Bimle C, Skoner D, McCoy K, Guthrie R. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants. Chest 2001;119:1749-1754. (Pubitemid 32744932)